References
- Baran R., Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol 2005; 19: 21–9
- Elewski B. E. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 1998; 11: 415–29
- Gupta A. K., Ryder J. E., Baran R. The use of topical therapies to treat onychomycosis. Dermatol Clin 2003; 21: 481–9
- Evans E. G. Drug synergies and the potential for combination therapy in onychomycosis. Br J Dermatol 2003; 149((Suppl 65))11–13
- Gupta A. K., Ryder J. E., Skinner A. R. Treatment of onychomycosis: pros and cons of antifungal agents. J Cutan Med Surg 2004; 8: 25–30
- Olafsson J. H., Sigurgeirsson B., Baran R. Combination therapy for onychomycosis. Br J Dermatol 2003; 149((Suppl 65))15–18
- Roberts D. T., Taylor W. D., Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003; 148: 402–10
- Bohn M., Kraemer K. T. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. J Am Acad Dermatol 2000; 43: S57–S69
- Seebacher C. Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. Mycoses 2003; 46: 506–10
- Gupta A. K. Ciclopirox nail lacquer: a brush with onychomycosis. Cutis 2001; 68: 13–16
- Gupta A. K., Ryder J. E., Johnson A. M. Cumulative meta‐analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 2004; 150: 537–44
- Gupta A. K., Lynch L. E. Management of onychomycosis: examining the role of monotherapy and dual, triple, or quadruple therapies. Cutis 2004; 74: 5–9
- aran R., de Doncker P. Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals. Acta Derm Venereol 1996; 76: 82–3